نتائج البحث - "Rosario Iaffaioli"

1

Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a

المساهمون: Barni, Sandro, Rosati, Gerardo, Lonardi, Sara, Pella, Nicoletta, Banzi, Maria, Zampino, Maria G, Dotti, Katia F, Rimassa, Lorenza, Marchetti, Paolo, Maiello, Evaristo, Artioli, Fabrizio, Ferrari, Dari, Labianca, Roberto, Bidoli, Paolo, Zaniboni, Alberto, Sobrero, Alberto, Iaffaioli, Vincenzo, De Placido, Sabino, Frassineti, Gian Luca, Ciarlo, Andrea, Buonadonna, Angela, Silvestris, Nicola, Piazza, Elena, Pavesi, Lorenzo, Moroni, Mauro, Clerico, Mario, Aglietta, Massimo, Giordani, Paolo, Galli, Francesca, Galli, Fabio, Petrelli, Fausto, Barni, S, Rosati, G, Lonardi, S, Pella, N, Banzi, M, Zampino, M, Dotti, K, Rimassa, L, Marchetti, P, Maiello, E, Artioli, F, Ferrari, D, Labianca, R, Bidoli, P, Zaniboni, A, Sobrero, A, Iaffaioli, V, De Placido, S, Frassineti, G, Ciarlo, A, Buonadonna, A, Silvestris, N, Piazza, E, Pavesi, L, Moroni, M, Clerico, M, Aglietta, M, Giordani, P, Galli, F, Petrelli, F

المصدر: Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, Phases of clinical research, Khorana score, colorectal cancer, lcsh:RC254-282, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Post-hoc analysis, adjuvant chemotherapy, thrombosis, medicine, thrombosi, Original Research, Cancer staging, business.industry, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Thrombosis, Adjuvant chemotherapy, 030220 oncology & carcinogenesis, Adjuvant chemotherapy, colorectal cancer, Khorana score, thrombosis, business, Risk assessment, Corrigendum, Adjuvant, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be2bb7a606ceef5eb33a00e2de29cdf
https://pubmed.ncbi.nlm.nih.gov/32547649

Find this article in full text from ProQuest

2

AXL is an oncotarget in human colorectal cancer

المساهمون: Martinelli, Erika, Martini, G, Cardone, C, Troiani, Teresa, Liguori, G, Vitagliano, D, Napolitano, S, Morgillo, Floriana, Rinaldi, Barbara, Melillo, Rm, Liotti, F, Nappi, A, Bianco, R, Berrino, Liberato, Ciuffreda, Lp, Ciardiello, D, Iaffaioli, V, Botti, G, Ferraiolo, F, Ciardiello, F., Martini, Giulia, Cardone, Claudia, Liguori, Giuseppina, Vitagliano, Donata, Napolitano, Stefania, Melillo, ROSA MARINA, Liotti, Federica, Nappi, Anna, Bianco, Roberto, Ciuffreda, Loreta Pia, Ciardiello, Davide, Iaffaioli, Vincenzo, Botti, Gerardo, Ferraiolo, Fiorella, Ciardiello, Fortunato

المصدر: Oncotarget
Europe PubMed Central
Oncotarget 6 (2015): 23281–23296. doi:10.18632/oncotarget.3962
info:cnr-pdr/source/autori:Martinelli, Erika; Martini, Giulia; Cardone, Claudia; Troiani, Teresa; Liguori, Giuseppina; Vitagliano, Donata; Napolitano, Stefania; Morgillo, Floriana; Rinaldi, Barbara; Melillo, Rosa Marina; Liotti, Federica; Nappi, Anna; Bianco, Roberto; Berrino, Liberato; Ciuffreda, Loreta Pia; Ciardiello, Davide; Iaffaioli, Vincenzo; Botti, Gerardo; Ferraiolo, Fiorella; Ciardiello, Fortunato/titolo:AXL is an oncotarget in human colorectal cancer/doi:10.18632%2Foncotarget.3962/rivista:Oncotarget/anno:2015/pagina_da:23281/pagina_a:23296/intervallo_pagine:23281–23296/volume:6

مصطلحات موضوعية: Male, Colorectal cancer, Angiogenesis, Receptor tyrosine kinase, chemistry.chemical_compound, Mice, Cell Movement, GAS6, Anilides, In Situ Hybridization, Fluorescence, Oligonucleotide Array Sequence Analysis, Aged, 80 and over, Mice, Inbred BALB C, Neovascularization, Pathologic, Middle Aged, Immunohistochemistry, Oncology, Quinolines, Intercellular Signaling Peptides and Proteins, Female, RNA Interference, Colorectal Neoplasms, Adult, foretinib, Cell Survival, Mice, Nude, colorectal cancer, Antineoplastic Agents, Biology, FISH, Cell Line, Tumor, Proto-Oncogene Proteins, Pathology Section, medicine, Gene silencing, Animals, Humans, Gene Silencing, neoplasms, Aged, Cell Proliferation, Cell growth, Foretinib, AXL, Receptor Protein-Tyrosine Kinases, medicine.disease, HCT116 Cells, Axl Receptor Tyrosine Kinase, digestive system diseases, Research Paper: Pathology, chemistry, Cancer research, biology.protein, Neoplasm Transplantation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c3a58af6c1e8909557c8cca4cb94a0
http://europepmc.org/articles/PMC4695118

3

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial

المؤلفون: Andrea Onetti Muda, Guido Giordano, Gianni Simone, Pietro Micheli, C. Barone, Giacomo Cartenì, Fabiana Tatangelo, Laura Longhitano, Vincenzo Rosario Iaffaioli, Alessandra Cassano, M. Biglietto, Anna Nappi, Sabrina Rossi, A.R. Bordonaro, A. Rinaldi, Francesco Sponziello, G. Modoni, GabrieleDi Maggio, Matilde Lambiase, Oscar Nappi, Claudia Cardone, Antonella Marino, Mirko Montrone, Sandro Barni, Michele Orditura, Antonio Febbraro, Paolo Graziano, Saverio Cinieri, Guglielmo Nasti, Fortunato Ciardiello, Evaristo Maiello, D. Rizzi, Vincenzo Sforza, Stefano Cordio, F. De Vita, Erika Martinelli, S. Romito, Vincenzo Montesarchio, Giuseppe Tonini, Annamaria Sebastio, Salvatore Pisconti, Nicola Normanno, Tiziana Guarino, Giuseppe Colucci, Francesco Giuliani, Anna Maria Rachiglio, Gerardo Botti, Nicoletta Chicchinelli, Tiziana Latiano, Teresa Troiani, Vito Lorusso, Michele Aieta, Silvana Leo, Giuseppe Grimaldi, Eugenio Tommaselli, Luigi Leo, Cinzia Chiarazzo, Mario Manusia

المساهمون: Martinelli, E, Cardone, C, Troiani, T, Normanno, N, Pisconti, S, Sforza, V, Bordonaro, A R, Rachiglio, A M, Lambiase, M, Latiano, T P, Modoni, G, Cordio, S, Giuliani, F, Biglietto, M, Montesarchio, V, Barone, C, Tonini, G, Cinieri, Enrico, Febbraro, A, Rizzi, D, De Vita, F, Orditura, M, Colucci, G, Maiello, E, Ciardiello, F

المصدر: ESMO Open

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Population, colorectal cancer, medicine.disease_cause, elderly, FOLFIRI, FOLFOX, Internal medicine, cetuximab, Medicine, education, neoplasms, Original Research, education.field_of_study, Cetuximab, business.industry, digestive system diseases, Oxaliplatin, Irinotecan, Tolerability, NGS, KRAS, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af94c5e34d30a0c5c6081a0ae97b5355
http://europepmc.org/articles/PMC5548975

Full Text via ClinicalKey

4

Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed

المؤلفون: Elena Di Gennaro, Antonio Avallone, Alfredo Budillon, Vincenzo Rosario Iaffaioli, Lucrezia Silvestro

المصدر: Expert Opinion on Drug Safety. 13:113-129

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef0b9f57afc287dda7fde84e35fa6da
https://doi.org/10.1517/14740338.2014.845167

PDF full text from Publisher

5

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)

المساهمون: Aloj, Luigi [0000-0002-7452-4961], Apollo - University of Cambridge Repository, Avallone, A., Piccirillo, M. C., Aloj, L., Nasti, G., Delrio, P., Izzo, F., Di Gennaro, E., Tatangelo, F., Granata, V., Cavalcanti, E., Maiolino, P., Bianco, F., Aprea, P., De Bellis, M., Pecori, B., Rosati, G., Carlomagno, C., Bertolini, A., Gallo, C., Romano, C., Leone, A., Caraco, C., de Lutio di Castelguidone, E., Daniele, G., Catalano, O., Botti, G., Petrillo, A., Romano, G. M., Iaffaioli, V. R., Lastoria, S., Perrone, F., Budillon, A., Avallone, Antonio, Piccirillo, Maria Carmela, Aloj, Luigi, Nasti, Guglielmo, Delrio, Paolo, Izzo, Francesco, Di Gennaro, Elena, Tatangelo, Fabiana, Granata, Vincenza, Cavalcanti, Ernesta, Maiolino, Piera, Bianco, Francesco, Aprea, Pasquale, De Bellis, Mario, Pecori, Biagio, Rosati, Gerardo, Carlomagno, Chiara, Bertolini, Alessandro, Gallo, Ciro, Romano, Carmela, Leone, Alessandra, Caracò, Corradina, de Lutio di Castelguidone, Elisabetta, Daniele, Gennaro, Catalano, Orlando, Botti, Gerardo, Petrillo, Antonella, Romano, Giovanni M., Iaffaioli, Vincenzo R., Lastoria, Secondo, Perrone, Francesco, Budillon, Alfredo

المصدر: BMC Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Vascular Endothelial Growth Factor A, Cancer Research, Organoplatinum Compounds, Colorectal cancer, Leucovorin, Phases of clinical research, Colorectal Neoplasm, Study Protocol, 0302 clinical medicine, FOLFOX, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, FDG-PET, Antibodies, Monoclonal, Middle Aged, Prognosis, Oxaliplatin, Bevacizumab, 030220 oncology & carcinogenesis, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Human, Adult, medicine.medical_specialty, Prognosi, Antibodies, Monoclonal, Humanized, Biomarkers for anti-angiogenic therapy, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Genetics, Humans, Aged, Antineoplastic Combined Chemotherapy Protocol, business.industry, Organoplatinum Compound, medicine.disease, Clinical trial, Regimen, 030104 developmental biology, Vessel normalization, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d2c093c0d75a59dadb15dfa3e05826
https://www.repository.cam.ac.uk/handle/1810/287183

6

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

المؤلفون: Francesco Sponziello, Saverio Cinieri, Giuseppe Grimaldi, Alessandra Cassano, M. Biglietto, Pietro Micheli, Gianni Simone, C. Barone, Fabiana Tatangelo, Antonella Marino, Giacomo Cartenì, Guglielmo Nasti, D. Rizzi, Antonio Febbraro, Cinzia Chiarazzo, Mario Manusia, Vito Lorusso, Fortunato Ciardiello, A.R. Bordonaro, S. Romito, Sabrina Rossi, Teresa Troiani, F. De Vita, Eugenio Tommaselli, Giuseppe Colucci, Andrea Onetti Muda, Guido Giordano, Luigi Leo, G. Modoni, Annamaria Sebastio, Sandro Barni, Francesco Giuliani, Paolo Graziano, M. Rachiglio, Michele Aieta, Evaristo Maiello, Enrica Martinelli, Mirko Montrone, Silvana Leo, Tiziana Latiano, Stefano Cordio, Laura Longhitano, Vincenzo Rosario Iaffaioli, Vincenzo Montesarchio, Nicola Normanno, Anna Nappi, Matilde Lambiase, Gerardo Botti, Gabriele Di Maggio, Giuseppe Tonini, Nicoletta Chicchinelli, Oscar Nappi, Claudia Cardone, Michele Orditura, A. Rinaldi, Salvatore Pisconti, Tiziana Guarino

المساهمون: Ciardiello, Fortunato, Normanno, N, Martinelli, Erika, Troiani, Teresa, Pisconti, S, Cardone, C, Nappi, A, Bordonaro, Ar, Rachiglio, M, Lambiase, M, Latiano, Tp, Modoni, G, Cordio, S, Giuliani, F, Biglietto, M, Montesarchio, V, Barone, C, Tonini, G, Cinieri, S, Febbraro, A, Rizzi, D, DE VITA, Ferdinando, Orditura, Michele, Colucci, G, Maiello, E, CAPRI GOIM, Investigator, CAPRI GOIM, Investigators

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Organoplatinum Compounds, Class I Phosphatidylinositol 3-Kinases, Leucovorin, Phases of clinical research, colorectal cancer, medicine.disease_cause, Disease-Free Survival, Cetuximab, Colorectal cancer, FOLFOX, NGS, Hematology, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Folinic acid, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, cetuximab, Medicine, Humans, Neoplasm Metastasis, neoplasms, Proportional Hazards Models, Settore MED/06 - ONCOLOGIA MEDICA, business.industry, digestive system diseases, Oxaliplatin, Irinotecan, 030104 developmental biology, Treatment Outcome, Italy, 030220 oncology & carcinogenesis, FOLFIRI, Female, KRAS, Fluorouracil, business, Colorectal Neoplasms, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343fea2703fb6409297f48937f6f6bde
http://hdl.handle.net/11591/354385

7

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort

المساهمون: M., Barba, F., Sperati, S., Strange, Carlomagno, Chiara, G., Nasti, V., Iaffaioli, G., Caolo, M., Mottolese, G., Botti, I., Terrenato, P., Vici, Serpico, Danila, A., Giordano, G., D’Aiuto, A., Crispo, M., Montella, G., Capurso, G., Delle Fave, B., Fuhrman, C., Botti, DE PLACIDO, Sabino

المصدر: Annals of Oncology. 23:1838-1845

مصطلحات موضوعية: Male, Blood Glucose, Oncology, targeted agents, Colorectal cancer, Drug Resistance, Cetuximab, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Breast Neoplasms, Colorectal Neoplasms, Disease-Free Survival, Drug Resistance, Neoplasm, Fasting, Female, Humans, Middle Aged, Molecular Targeted Therapy, Multivariate Analysis, Proportional Hazards Models, Retrospective Studies, Treatment Outcome, Tumor Markers, Biological, Monoclonal, Prospective cohort study, Humanized, Tumor Markers, Hematology, Bevacizumab, Cohort, medicine.drug, medicine.medical_specialty, colorectal cancer, Antibodies, breast cancer, Breast cancer, Internal medicine, Biomarkers, Tumor, medicine, Proportional hazards model, business.industry, Cancer, Retrospective cohort study, Original Articles, Trastuzumab, Biological, medicine.disease, Surgery, Neoplasm, fasting glucose, business